bpc-157 safety evidence clinical trials BPC-157: Evidence, Uses, & Current Status 10 questions to ask your – bpc-157 safety evidence human studies

While not FDA-approved or intended to treat medical conditions, early research and anecdotal experiences suggest BPC-157 may support: Post-exercise recovery Joint and connective tissue resilience Gut lining health General inflammation response Many users include it in their peptide wellness stacks for long-term recovery and vitality goals

Contraindicated in pregnancy and breastfeeding due to absence of safety data

The World Anti-Doping Agencys Prohibited List classifies BPC-157 under S0 Non-Approved Substances, noting it has no approval from any governmental regulatory health authority for human therapeutic use and no established safe dose

BPC-157 is not a first-line treatment for most conditions